Company: ZLAB
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001628280-25-008409
Chunk: 40

Company: Zai Lab Ltd
Filing Date: 2025-02-27
Form: 10-K
Item: Item 16
Chunk 40
---
 31,202420232022Operating fixed lease cost8,751 8,691 8,774 

F-21

Zai Lab LimitedNotes to the Consolidated Financial StatementsFor the Years Ended December 31, 2024, 2023, and 2022

The following table presents operating cash flows related to leases ($ in thousands):Year Ended December 31,202420232022Cash paid for amounts included in measurement of lease liabilities8,831 9,317 8,084 Non-cash operating lease liabilities arising from obtaining operating right-of-use assets15,150 3,668 14,801 The maturities of lease liabilities in accordance with ASC 842, Leases in each of the next five years and thereafter were as follows ($ in thousands): Year EndedDecember 31, 202420258,611 20264,994 20273,725 20282,908 20292,312 Thereafter609 Total lease payments23,159 Less: imputed interest(1,399)Present value of minimum operating lease payments21,760 Weighted-average remaining lease terms and discount rates were as follows: December 31,20242023Weighted-average remaining lease term3.7 years2.5 yearsWeighted-average discount rate3.4 %3.0 %

9. Intangible Assets, Net 

The following table presents the components of the Company’s intangible assets, net ($ in thousands):As of December 31,20242023Gross Carrying AmountAccumulated AmortizationNet Carrying ValueGross Carrying AmountAccumulated AmortizationNet Carrying ValueFinite-lived intangible assetsCommercial products (i)57,104 (2,637)54,467 11,351 (186)11,165 Software4,360 (2,800)1,560 4,340 (2,116)2,224 Total61,464 (5,437)56,027 15,691 (2,302)13,389 (i) The increase in the net carrying value is primarily driven by $33.4 million of regulatory milestone fees for repotrectinib and SUL-DUR (see Note 16) and $12.2 million of acquired commercial manufacturing know-how and related development costs.   

F-22

Zai Lab LimitedNotes to the Consolidated Financial StatementsFor the Years Ended December